PsiThera, formerly Psivant Therapeutics, raised just over $47 million for oral drugs targeting “diseases long-constrained by ...
The agency gave the green light to a U.S. company manufacturing Augmentin XR, an antibiotic first approved more than two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback